These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 27095464)

  • 1. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
    Blaes F; Dharmalingam B
    Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New autoantibodies in pediatric opsoclonus myoclonus syndrome.
    Kirsten A; Beck S; Fühlhuber V; Kaps M; Kreutz T; Korfei M; Schmitt S; Preissner KT; Blaes F
    Ann N Y Acad Sci; 2007 Sep; 1110():256-60. PubMed ID: 17911440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood opsoclonus-myoclonus syndrome: A case series from Tunisia.
    Ben Achour N; Mrabet S; Rebai I; Abid I; Benrhouma H; Klaa H; Rouissi A; Kraoua I; Ben Youssef Turki I
    Brain Dev; 2017 Oct; 39(9):751-755. PubMed ID: 28549713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Opsoclonus myoclonus ataxia syndrome in Israel].
    Blumkin L; Lerman-Sagie T
    Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
    Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F
    Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour].
    Jamroz E; Głuszkiewicz E; Madziara W; Kiełtyka A
    Med Wieku Rozwoj; 2011; 15(2):151-6. PubMed ID: 22002047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management.
    Gupta A; Kundal R; Pandey M
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):1086-1088. PubMed ID: 35932142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile and outcome of children with opsoclonus-myoclonus syndrome.
    Singhi P; Sahu JK; Sarkar J; Bansal D
    J Child Neurol; 2014 Jan; 29(1):58-61. PubMed ID: 23318697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraneoplastic opsoclonus-myoclonus syndrome--a review].
    Matsumoto H; Ugawa Y
    Brain Nerve; 2010 Apr; 62(4):365-9. PubMed ID: 20420176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic opsoclonus-myoclonus syndrome (POMS)].
    Matsumoto H; Ugawa Y
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():763-7. PubMed ID: 26480791
    [No Abstract]   [Full Text] [Related]  

  • 11. Opsoclonus-myoclonus syndrome following rotavirus gastroenteritis.
    Gurkas E; Gucuyener K; Yılmaz U; Havalı C; Demir E
    Pediatr Int; 2014 Dec; 56(6):e86-e87. PubMed ID: 25521990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report.
    Reinecke R; Reiländer A; Seiler A; Koch C; Voss M
    BMC Neurol; 2022 Dec; 22(1):507. PubMed ID: 36581905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome.
    Beck S; Fühlhuber V; Krasenbrink I; Tschernatsch M; Kneifel N; Kirsten A; Jaeger C; Kaps M; Preissner KT; Lang B; Rostasy K; Blaes F
    J Neuroimmunol; 2007 Apr; 185(1-2):145-9. PubMed ID: 17324472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in childhood opsoclonus-myoclonus syndrome.
    Blaes F; Pike MG; Lang B
    J Neuroimmunol; 2008 Sep; 201-202():221-6. PubMed ID: 18687475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opsoclonus–myoclonus syndrome.
    Sahu JK; Prasad K
    Pract Neurol; 2011 Jun; 11(3):160-6. PubMed ID: 21551110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children.
    Pranzatelli MR; Tate ED; McGee NR
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27097. PubMed ID: 29727049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
    Burke MJ; Cohn SL
    Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK Cell-mediated Neuroblastoma Cell Lysis is Enhanced by IgG From Patients With Pediatric Opsoclonus-Myoclonus Syndrome.
    Zar T; Tschernatsch M; Hero B; Lang B; Preissner KT; Blaes F
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e176-e179. PubMed ID: 33060390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of autoantigens in pediatric opsoclonus-myoclonus syndrome.
    Blaes F; Fühlhuber V; Preissner KT
    Expert Rev Clin Immunol; 2007 Nov; 3(6):975-82. PubMed ID: 20477144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute transverse myelitis following an opsoclonus-myoclonus syndrome: An unusual presentation.
    Simon T; Cheuret E; Fiedler L; Mengelle C; Baudou E; Deiva K
    Eur J Paediatr Neurol; 2018 Sep; 22(5):878-881. PubMed ID: 29773357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.